SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-244385
Filing Date
2017-08-01
Accepted
2017-08-01 17:18:53
Documents
67
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d415254d10q.htm 10-Q 558073
2 EX-10.1 d415254dex101.htm EX-10.1 802204
3 EX-10.2 d415254dex102.htm EX-10.2 172245
4 EX-31.1 d415254dex311.htm EX-31.1 9251
5 EX-31.2 d415254dex312.htm EX-31.2 9293
6 EX-32.1 d415254dex321.htm EX-32.1 5477
  Complete submission text file 0001193125-17-244385.txt   3974587

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lnth-20170630.xml EX-101.INS 506070
8 XBRL TAXONOMY EXTENSION SCHEMA lnth-20170630.xsd EX-101.SCH 40047
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lnth-20170630_cal.xml EX-101.CAL 66900
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lnth-20170630_def.xml EX-101.DEF 110638
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20170630_lab.xml EX-101.LAB 288999
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20170630_pre.xml EX-101.PRE 205509
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 17997577
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences